Clinical trial NCT02173977: Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVF
Official title: Ultrashort Flare GnRH Agonist Combined With Flexible Multidose GnRH Antagonist Versus Flexible Multidose GnRH Antagonist for Good-prognosis IVF Patients
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE2
Conditions: Infertility
Keywords: GnRH Agonist
GnRH Antagonist
OHSS
Lead sponsor: Sheba Medical Center
Sponsor class: OTHER_GOV
First posted: 2014-06-25
Enrollment: 200
Sex: FEMALE
Minimum age (years): 20
Maximum age (years): 35
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to evaluate the appropriate controlled ovarian hyperstimulation (COH) protocol in good prognosis patients undergoing IVF treatment. The stimulation characteristics of cycles which include ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist will be compared to the flexible multidose GnRH antagonist protocol.

The investigators hypothesized that combining the stimulatory effect of GnRH agonists and immediate suppression of the GnRH antagonist in a unique protocol may be a valuable new COH strategy for IVF patients, resulting in improved ART outcome.

Detailed description: The ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist protocol during COH cycle resulted in a significantly higher clinical pregnancy rate in patients with poor embryo quality, with repeated IVF failures and in poor responders. This protocol combines the effect of the microdose flare on endogenous follicle stimulating hormone (FSH) release with the benefit of an immediate luteinizing hormone suppression of the GnRH antagonist.

The basic hypothesis of this approach can also benefit IVF patients with good prognosis without compromising the ability to use gonadotrophin-releasing hormone (GnRH) agonist to effectively trigger ovulation, while completely eliminating any threat of clinically significant ovarian hyperstimulation syndrome (OHSS).

The purpose of the study is to compare cycles consisting of ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist with those using the flexible multidose GnRH antagonist protocol

1. To compare the IVF outcome variables and ongoing pregnancy rates.

Eligibility criteria: Inclusion Criteria:

* Up to three previous IVF attempts

Exclusion Criteria:

* Patients with poor or no response in previous COH for IVF cycles
* Abnormal ovarian reserve test i.e. anti-mullerian hormone (AMH), Antral follicle test
* Risk factor for Diminished Ovarian Reserve

Primary outcomes:
measure: Ongoing pregnancy rates
timeFrame: 2 years
Secondary outcomes:
measure: Total gonadotropin use
timeFrame: 2 Years
measure: Biochemical pregnancy
timeFrame: 2 Years
measure: Clinical pregnancy
timeFrame: 2 Years
measure: Multiple pregnancy rate
timeFrame: 2 Years
measure: Miscarriage rate
timeFrame: 2 Years
measure: Fertilization rate
timeFrame: 2 Years
measure: Number of oocytes
timeFrame: 2 years
measure: OHSS rates
timeFrame: 2 Years
measure: Embryo quality
timeFrame: 2 Years
Other outcomes:
measure: Positive Pregnancy Test
timeFrame: 2 Years
Locations:
city: Ramat Gan
country: Israel
facility: Sheba Medical Center- IVF unit
Study officials:
affiliation: Infertility & IVF Unit, Dept. Obstetrics & Gynecology - Director
name: Raoul Orvieto, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Orvieto R, Nahum R, Rabinson J, Gemer O, Anteby EY, Meltcer S. Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality. Fertil Steril. 2009 Apr;91(4 Suppl):1398-400. doi: 10.1016/j.fertnstert.2008.04.064. Epub 2008 Aug 3.
citation: Orvieto R. The ultrashort flare GnRH-agonist/GnRH-antagonist protocol enables cycle programming and may overcome the "detrimental effect" of the oral contraceptive. Fertil Steril. 2012 Sep;98(3):e17-8; author reply e19. doi: 10.1016/j.fertnstert.2012.06.053. Epub 2012 Jul 26. No abstract available.
citation: Orvieto R, Nahum R, Zohav E, Liberty G, Anteby EY, Meltcer S. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol. Gynecol Endocrinol. 2013 Jan;29(1):51-3. doi: 10.3109/09513590.2012.705376. Epub 2012 Aug 3.
citation: Orvieto R, Meltcer S, Liberty G, Rabinson J, Anteby EY, Nahum R. A combined approach to patients with repeated IVF failures. Fertil Steril. 2010 Nov;94(6):2462-4. doi: 10.1016/j.fertnstert.2010.03.057. Epub 2010 May 7.
citation: Orvieto R, Kruchkovich J, Rabinson J, Zohav E, Anteby EY, Meltcer S. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs. Fertil Steril. 2008 Jul;90(1):228-30. doi: 10.1016/j.fertnstert.2007.06.022. Epub 2007 Aug 6.